z-logo
open-access-imgOpen Access
Donepezil Therapy in Clinical Practice
Author(s) -
Steven M. Greenberg,
Marsha Tennis,
Laura B. Brown,
Teresa GómezIsla,
Ivor S. Douglas,
David Schoenfeld,
Katie L. Walsh,
Claire Corwin,
Kirk R. Daffner,
Pamela Friedman,
MaryEllen Meadows,
Reisa A. Sperling,
John H. Growdon
Publication year - 2000
Publication title -
archives of neurology
Language(s) - English
Resource type - Journals
eISSN - 1538-3687
pISSN - 0003-9942
DOI - 10.1001/archneur.57.1.94
Subject(s) - donepezil , placebo , rivastigmine , medicine , clinical global impression , tacrine , dementia , randomized controlled trial , adverse effect , nausea , alzheimer's disease , crossover study , verbal fluency test , psychology , psychiatry , cognition , disease , neuropsychology , biochemistry , chemistry , alternative medicine , pathology , acetylcholinesterase , enzyme
To determine the efficacy of donepezil hydrochloride for the treatment of Alzheimer disease in patients drawn from clinical practice.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom